Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Juhi, Husain"'
Autor:
Parneet K. Cheema, Marco A. J. Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Priscilla Matthews, William R. Raskin, Kirstin A. Perdrizet, Shaan Dudani, Juhi Husain, Margaret Balcewicz, Philip G. Kuruvilla, Stephen M. Reingold, Henry J. Conter
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 869-880 (2022)
The increased use of immune checkpoint inhibitors across cancer programs has created the need for standardized patient assessment, education, monitoring, and management of immune-related adverse events (irAEs). At William Osler Health System in Bramp
Externí odkaz:
https://doaj.org/article/a6006115821a4207b3e6e19870a4a5d7
Autor:
Parneet K. Cheema, Marco A. J. Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Priscilla Matthews, William R. Raskin, Kirstin A. Perdrizet, Shaan Dudani, Juhi Husain, Margaret Balcewicz, Philip G. Kuruvilla, Stephen M. Reingold, Henry J. Conter
Publikováno v:
Current oncology (Toronto, Ont.). 29(2)
The increased use of immune checkpoint inhibitors across cancer programs has created the need for standardized patient assessment, education, monitoring, and management of immune-related adverse events (irAEs). At William Osler Health System in Bramp
Autor:
Ravnoor Kang, Rachel Dhir, Marco Iafolla, William Raskin, Shaan Dudani, Juhi Husain, Margaret Balcewicz, Philip G. Kuruvilla, Stephen Reingold, Henry Jacob Conter, Shyam Ravisankar, Rardi Van Heest, Parneet Kaur Cheema, Kirstin Perdrizet
Publikováno v:
Journal of Clinical Oncology. 40:e18631-e18631
e18631 Background: Cancer patients have a high risk of severe illness from COVID-19 infection, and the William Osler Health System oncology clinic (WOHS-OC) is in Brampton, ON, Canada, a COVID-19 hotspot with high community COVID-19 prevalence. As su
Autor:
Monika K Krzyzanowska, Jim A Julian, Chu-Shu Gu, Melanie Powis, Qing Li, Katherine Enright, Doris Howell, Craig C Earle, Sonal Gandhi, Sara Rask, Christine Brezden-Masley, Susan Dent, Leena Hajra, Orit Freeman, Silvana Spadafora, Caroline Hamm, Nadia Califaretti, Maureen Trudeau, Mark N Levine, Eitan Amir, Louise Bordeleau, James A Chiarotto, Christine Elser, Juhi Husain, Nicole Laferriere, Yasmin Rahim, Andrew G Robinson, Ted Vandenberg, Eva Grunfeld
Publikováno v:
The BMJ
ObjectiveTo evaluate the effectiveness of remote proactive management of toxicities during chemotherapy for early stage breast cancer.DesignPragmatic, cluster randomised trial.Setting20 cancer centres in Ontario, Canada, allocated by covariate constr
Autor:
Janet Papadakos, FeRevelyn Berco, Massey Nematollahi, Kirstin Perdrizet, Henry Jacob Conter, Stephen Reingold, Deepanjali Kaushik, Margaret Balcewicz, Parneet Cheema, Priscilla M Matthews, Philip Kuruvilla, Juhi Husain, Marco A. J. Iafolla, William Raskin
Publikováno v:
Journal of Clinical Oncology. 38:2032-2032
2032 Background: ICIs have unique side effects of immune related adverse events (irAEs). For early detection and management of irAEs, at a large community hospital we implemented a standard IO nursing baseline assessment, education and monitoring pro
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 4:1131-1141
Lepirudin is a recombinant hirudin that exerts its anticoagulant effect by direct inhibition of thrombin. Lepirudin is indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease to prev
Publikováno v:
Oncology (Williston Park, N.Y.). 22(8)
Granulocytic sarcomas (GS) are uncommon extramedullary tumors composed of immature cells of the granulocytic or myeloid series. Treatment for GS should be directed toward the underlying hematologic disorder. There is no standard treatment.
Publikováno v:
American journal of hematology. 83(3)
Argatroban is a direct thrombin inhibitor approved for the treatment of heparin-induced thrombocytopenia (HIT) type II. Argatroban is predominantly metabolized in the liver. It is widely believed that no dosage adjustment is required in patients with
Autor:
Thomas L. Schwartz, Nouman Azhar, Douglas Coovert, Nikhil Nihalani, Syed Tirmazi, Mihai Simionescu, Shefali Jindal, Juhi Husain
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 17(3)
At least 50% of patients with anxiety disorders experience only partial response to pharmacotherapy and require augmentation therapy. Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the CNS, and agents that modulate GABA ne
Autor:
Thomas L. Schwartz, Nikhil Nihalani, Nicole Jones, Nouman Azhar, Geoffrey Hopkins, Mihai Simionescu, Kim Cole, Juhi Husain
Publikováno v:
The Journal of clinical psychiatry. 65(9)
Objective: In patients with major depressive disorder (MDD), excessive sleepiness and fatigue not only are major components of the disorder, but also may occur as side effects of antidepressant therapy. In addition, sedation may he a consequence of a